Global Drugs Based on CAR T-cell Market Growth (Status and Outlook) 2022-2028
- LP 4977932
- 88 Pages
- July 2022
- Pharmaceuticals
The United States Drugs Based on CAR T-cell market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Drugs Based on CAR T-cell market, reaching US$ million by the year 2028. As for the Europe Drugs Based on CAR T-cell landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Drugs Based on CAR T-cell players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, and J & J, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs Based on CAR T-cell market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CD19-targeted
BCMA-targeted
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Lymphoma
Multiple Myeloma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs Based on CAR T-cell Market Size 2017-2028
2.1.2 Drugs Based on CAR T-cell Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drugs Based on CAR T-cell Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 Drugs Based on CAR T-cell Market Size by Type
2.3.1 Drugs Based on CAR T-cell Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drugs Based on CAR T-cell Market Size Market Share by Type (2017-2022)
2.4 Drugs Based on CAR T-cell Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 Drugs Based on CAR T-cell Market Size by Application
2.5.1 Drugs Based on CAR T-cell Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drugs Based on CAR T-cell Market Size Market Share by Application (2017-2022)
3 Drugs Based on CAR T-cell Market Size by Player
3.1 Drugs Based on CAR T-cell Market Size Market Share by Players
3.1.1 Global Drugs Based on CAR T-cell Revenue by Players (2020-2022)
3.1.2 Global Drugs Based on CAR T-cell Revenue Market Share by Players (2020-2022)
3.2 Global Drugs Based on CAR T-cell Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs Based on CAR T-cell by Regions
4.1 Drugs Based on CAR T-cell Market Size by Regions (2017-2022)
4.2 Americas Drugs Based on CAR T-cell Market Size Growth (2017-2022)
4.3 APAC Drugs Based on CAR T-cell Market Size Growth (2017-2022)
4.4 Europe Drugs Based on CAR T-cell Market Size Growth (2017-2022)
4.5 Middle East & Africa Drugs Based on CAR T-cell Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drugs Based on CAR T-cell Market Size by Country (2017-2022)
5.2 Americas Drugs Based on CAR T-cell Market Size by Type (2017-2022)
5.3 Americas Drugs Based on CAR T-cell Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs Based on CAR T-cell Market Size by Region (2017-2022)
6.2 APAC Drugs Based on CAR T-cell Market Size by Type (2017-2022)
6.3 APAC Drugs Based on CAR T-cell Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs Based on CAR T-cell by Country (2017-2022)
7.2 Europe Drugs Based on CAR T-cell Market Size by Type (2017-2022)
7.3 Europe Drugs Based on CAR T-cell Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs Based on CAR T-cell by Region (2017-2022)
8.2 Middle East & Africa Drugs Based on CAR T-cell Market Size by Type (2017-2022)
8.3 Middle East & Africa Drugs Based on CAR T-cell Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs Based on CAR T-cell Market Forecast
10.1 Global Drugs Based on CAR T-cell Forecast by Regions (2023-2028)
10.1.1 Global Drugs Based on CAR T-cell Forecast by Regions (2023-2028)
10.1.2 Americas Drugs Based on CAR T-cell Forecast
10.1.3 APAC Drugs Based on CAR T-cell Forecast
10.1.4 Europe Drugs Based on CAR T-cell Forecast
10.1.5 Middle East & Africa Drugs Based on CAR T-cell Forecast
10.2 Americas Drugs Based on CAR T-cell Forecast by Country (2023-2028)
10.2.1 United States Drugs Based on CAR T-cell Market Forecast
10.2.2 Canada Drugs Based on CAR T-cell Market Forecast
10.2.3 Mexico Drugs Based on CAR T-cell Market Forecast
10.2.4 Brazil Drugs Based on CAR T-cell Market Forecast
10.3 APAC Drugs Based on CAR T-cell Forecast by Region (2023-2028)
10.3.1 China Drugs Based on CAR T-cell Market Forecast
10.3.2 Japan Drugs Based on CAR T-cell Market Forecast
10.3.3 Korea Drugs Based on CAR T-cell Market Forecast
10.3.4 Southeast Asia Drugs Based on CAR T-cell Market Forecast
10.3.5 India Drugs Based on CAR T-cell Market Forecast
10.3.6 Australia Drugs Based on CAR T-cell Market Forecast
10.4 Europe Drugs Based on CAR T-cell Forecast by Country (2023-2028)
10.4.1 Germany Drugs Based on CAR T-cell Market Forecast
10.4.2 France Drugs Based on CAR T-cell Market Forecast
10.4.3 UK Drugs Based on CAR T-cell Market Forecast
10.4.4 Italy Drugs Based on CAR T-cell Market Forecast
10.4.5 Russia Drugs Based on CAR T-cell Market Forecast
10.5 Middle East & Africa Drugs Based on CAR T-cell Forecast by Region (2023-2028)
10.5.1 Egypt Drugs Based on CAR T-cell Market Forecast
10.5.2 South Africa Drugs Based on CAR T-cell Market Forecast
10.5.3 Israel Drugs Based on CAR T-cell Market Forecast
10.5.4 Turkey Drugs Based on CAR T-cell Market Forecast
10.5.5 GCC Countries Drugs Based on CAR T-cell Market Forecast
10.6 Global Drugs Based on CAR T-cell Forecast by Type (2023-2028)
10.7 Global Drugs Based on CAR T-cell Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Drugs Based on CAR T-cell Product Offered
11.1.3 Novartis Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Drugs Based on CAR T-cell Product Offered
11.2.3 Gilead Sciences Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Drugs Based on CAR T-cell Product Offered
11.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J Drugs Based on CAR T-cell Product Offered
11.4.3 J & J Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics Drugs Based on CAR T-cell Product Offered
11.5.3 JW Therapeutics Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite Drugs Based on CAR T-cell Product Offered
11.6.3 FOSUNKite Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
12 Research Findings and Conclusion
Table 1. Drugs Based on CAR T-cell Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CD19-targeted
Table 3. Major Players of BCMA-targeted
Table 4. Drugs Based on CAR T-cell Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drugs Based on CAR T-cell Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drugs Based on CAR T-cell Market Size Market Share by Type (2017-2022)
Table 7. Drugs Based on CAR T-cell Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drugs Based on CAR T-cell Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drugs Based on CAR T-cell Market Size Market Share by Application (2017-2022)
Table 10. Global Drugs Based on CAR T-cell Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drugs Based on CAR T-cell Revenue Market Share by Player (2020-2022)
Table 12. Drugs Based on CAR T-cell Key Players Head office and Products Offered
Table 13. Drugs Based on CAR T-cell Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drugs Based on CAR T-cell Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drugs Based on CAR T-cell Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drugs Based on CAR T-cell Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drugs Based on CAR T-cell Market Size Market Share by Country (2017-2022)
Table 20. Americas Drugs Based on CAR T-cell Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drugs Based on CAR T-cell Market Size Market Share by Type (2017-2022)
Table 22. Americas Drugs Based on CAR T-cell Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drugs Based on CAR T-cell Market Size Market Share by Application (2017-2022)
Table 24. APAC Drugs Based on CAR T-cell Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drugs Based on CAR T-cell Market Size Market Share by Region (2017-2022)
Table 26. APAC Drugs Based on CAR T-cell Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drugs Based on CAR T-cell Market Size Market Share by Type (2017-2022)
Table 28. APAC Drugs Based on CAR T-cell Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drugs Based on CAR T-cell Market Size Market Share by Application (2017-2022)
Table 30. Europe Drugs Based on CAR T-cell Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drugs Based on CAR T-cell Market Size Market Share by Country (2017-2022)
Table 32. Europe Drugs Based on CAR T-cell Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drugs Based on CAR T-cell Market Size Market Share by Type (2017-2022)
Table 34. Europe Drugs Based on CAR T-cell Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drugs Based on CAR T-cell Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drugs Based on CAR T-cell Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drugs Based on CAR T-cell Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drugs Based on CAR T-cell Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drugs Based on CAR T-cell Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drugs Based on CAR T-cell Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drugs Based on CAR T-cell Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drugs Based on CAR T-cell
Table 43. Key Market Challenges & Risks of Drugs Based on CAR T-cell
Table 44. Key Industry Trends of Drugs Based on CAR T-cell
Table 45. Global Drugs Based on CAR T-cell Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drugs Based on CAR T-cell Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drugs Based on CAR T-cell Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drugs Based on CAR T-cell Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drugs Based on CAR T-cell Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drugs Based on CAR T-cell Market Size Market Share Forecast by Application (2023-2028)
Table 51. Novartis Details, Company Type, Drugs Based on CAR T-cell Area Served and Its Competitors
Table 52. Novartis Drugs Based on CAR T-cell Product Offered
Table 53. Novartis Drugs Based on CAR T-cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Gilead Sciences Details, Company Type, Drugs Based on CAR T-cell Area Served and Its Competitors
Table 57. Gilead Sciences Drugs Based on CAR T-cell Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Drugs Based on CAR T-cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Gilead Sciences Latest Developments
Table 61. Bristol-Myers Squibb Details, Company Type, Drugs Based on CAR T-cell Area Served and Its Competitors
Table 62. Bristol-Myers Squibb Drugs Based on CAR T-cell Product Offered
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bristol-Myers Squibb Latest Developments
Table 66. J & J Details, Company Type, Drugs Based on CAR T-cell Area Served and Its Competitors
Table 67. J & J Drugs Based on CAR T-cell Product Offered
Table 68. J & J Main Business
Table 69. J & J Drugs Based on CAR T-cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. J & J Latest Developments
Table 71. JW Therapeutics Details, Company Type, Drugs Based on CAR T-cell Area Served and Its Competitors
Table 72. JW Therapeutics Drugs Based on CAR T-cell Product Offered
Table 73. JW Therapeutics Main Business
Table 74. JW Therapeutics Drugs Based on CAR T-cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. JW Therapeutics Latest Developments
Table 76. FOSUNKite Details, Company Type, Drugs Based on CAR T-cell Area Served and Its Competitors
Table 77. FOSUNKite Drugs Based on CAR T-cell Product Offered
Table 78. FOSUNKite Main Business
Table 79. FOSUNKite Drugs Based on CAR T-cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. FOSUNKite Latest Developments
List of Figures
Figure 1. Drugs Based on CAR T-cell Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs Based on CAR T-cell Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drugs Based on CAR T-cell Market Size Market Share by Type in 2021
Figure 7. Drugs Based on CAR T-cell in Lymphoma
Figure 8. Global Drugs Based on CAR T-cell Market: Lymphoma (2017-2022) & ($ Millions)
Figure 9. Drugs Based on CAR T-cell in Multiple Myeloma
Figure 10. Global Drugs Based on CAR T-cell Market: Multiple Myeloma (2017-2022) & ($ Millions)
Figure 11. Global Drugs Based on CAR T-cell Market Size Market Share by Application in 2021
Figure 12. Global Drugs Based on CAR T-cell Revenue Market Share by Player in 2021
Figure 13. Global Drugs Based on CAR T-cell Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Drugs Based on CAR T-cell Market Size 2017-2022 ($ Millions)
Figure 15. APAC Drugs Based on CAR T-cell Market Size 2017-2022 ($ Millions)
Figure 16. Europe Drugs Based on CAR T-cell Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Drugs Based on CAR T-cell Market Size 2017-2022 ($ Millions)
Figure 18. Americas Drugs Based on CAR T-cell Value Market Share by Country in 2021
Figure 19. Americas Drugs Based on CAR T-cell Consumption Market Share by Type in 2021
Figure 20. Americas Drugs Based on CAR T-cell Market Size Market Share by Application in 2021
Figure 21. United States Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Drugs Based on CAR T-cell Market Size Market Share by Region in 2021
Figure 26. APAC Drugs Based on CAR T-cell Market Size Market Share by Application in 2021
Figure 27. China Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Drugs Based on CAR T-cell Market Size Market Share by Country in 2021
Figure 34. Europe Drugs Based on CAR T-cell Market Size Market Share by Type in 2021
Figure 35. Europe Drugs Based on CAR T-cell Market Size Market Share by Application in 2021
Figure 36. Germany Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Drugs Based on CAR T-cell Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Drugs Based on CAR T-cell Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Drugs Based on CAR T-cell Market Size Market Share by Application in 2021
Figure 44. Egypt Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Drugs Based on CAR T-cell Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 50. APAC Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 51. Europe Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 53. United States Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 54. Canada Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 57. China Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 58. Japan Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 59. Korea Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 61. India Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 62. Australia Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 63. Germany Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 64. France Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 65. UK Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 66. Italy Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 67. Russia Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 68. Spain Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 71. Israel Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Drugs Based on CAR T-cell Market Size 2023-2028 ($ Millions)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
